Live feed07:30:00·7dPRReleasevia QuantisnowMedicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin SyndromeByQuantisnow·Wall Street's wire, on your screen.MDCX· Medicus Pharma Ltd.Health Care
